Cite
Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer.
MLA
Kang, Byung-Hee, et al. “Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 105, no. 1, Sept. 2019, pp. 104–09. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2019.03.011.
APA
Kang, B.-H., Yu, T., Kim, J. H., Park, J. M., Kim, J.-I., Chung, E.-J., Kwon, S. K., Kim, J.-H., & Wu, H.-G. (2019). Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer. International Journal of Radiation Oncology, Biology, Physics, 105(1), 104–109. https://doi.org/10.1016/j.ijrobp.2019.03.011
Chicago
Kang, Byung-Hee, Tosol Yu, Jin Ho Kim, Jong Min Park, Jung-In Kim, Eun-Jae Chung, Seong Keun Kwon, Ji-Hoon Kim, and Hong-Gyun Wu. 2019. “Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer.” International Journal of Radiation Oncology, Biology, Physics 105 (1): 104–9. doi:10.1016/j.ijrobp.2019.03.011.